UK markets closed

Centessa Pharmaceuticals plc (CNTA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.78+0.49 (+4.76%)
At close: 04:00PM EDT
10.78 0.00 (0.00%)
After hours: 05:35PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2020
31/12/2019
Total revenue
6,853
6,853
0
0
0
Operating expenses
Research development
114,231
124,405
155,083
9,301
4,263
Selling general and administrative
51,118
53,731
55,200
1,139
790
Total operating expenses
165,349
178,136
210,283
10,440
5,053
Operating income or loss
-158,496
-171,283
-210,283
-10,440
-5,053
Interest expense
10,090
9,906
7,277
378
118
Total other income/expenses net
-5,619
-5,428
362
155
105
Income before tax
-163,669
-176,141
-216,954
-10,663
-5,061
Income tax expense
-25,252
-25,056
-747
-
-
Income from continuing operations
-138,417
-151,085
-216,207
-10,663
-5,061
Net income
-138,417
-151,085
-216,207
-10,663
-5,061
Net income available to common shareholders
-138,417
-151,085
-216,207
-10,663
-5,061
Basic EPS
-0.15
-1.57
-2.31
-0.15
-0.07
Diluted EPS
-0.15
-1.57
-2.31
-0.15
-0.07
Basic average shares
70,891
96,178
93,401
70,891
70,891
Diluted average shares
70,891
96,178
93,401
70,891
70,891